Search clinical trials for: sorafenib (Nexavar®), thalidomide (Thado®)
Total 52 results
-
National Health Research Institutes, TaiwanChang Gung Memorial Hospital; National Cheng-Kung University HospitalTerminatedHepatocellular CarcinomaTaiwan
-
University of Kansas Medical CenterBayerCompletedRenal Cell CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedLiver Cancer | Hepatocellular CancerUnited States
-
Boston Scientific CorporationBiocompatibles UK LtdTerminatedHepatocellular CarcinomaSpain, United Kingdom, United States, Belgium, France, Italy
-
Yonsei UniversityCompletedHepatocellular CarcinomaKorea, Republic of
-
JSehouliCompleted
-
Centre Hospitalier Universitaire VaudoisCompletedOcular MelanomaSwitzerland
-
H. Lee Moffitt Cancer Center and Research InstituteTerminatedThyroid Cancer, Medullary | Thyroid Cancer | Papillary Thyroid Cancer | Differentiated Thyroid Cancer | Poorly Differentiated Thyroid Gland Carcinoma | Follicular Thyroid CancerUnited States
-
ExelixisActive, not recruitingHepatocellular CarcinomaUnited States, Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Colombia, Czechia, France, Georgia, Germany, Hong Kong, Hungary, Ireland, Israel, Italy, Korea, Republic of, Mexico, Netherlands, New Zealand, Philippines, ... and more
-
Sun Yat-sen UniversityUnknownGastrointestinal CancersChina
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); NovartisActive, not recruitingRefractory Hurthle Cell Thyroid CancerUnited States
-
PfizerTerminatedCarcinoma, HepatocellularUnited States, Belgium, Spain, Canada, Italy, Korea, Republic of, Poland, Turkey, Germany, Singapore, Taiwan, China, France, Hong Kong, South Africa, Australia, Japan, Sweden, Malaysia, Philippines, Thailand, Russian Federation, United...
-
Air Force Military Medical University, ChinaUnknown
-
Southern Europe New Drug OrganizationBayer; NovartisSuspendedAdvanced Solid TumorsItaly
-
Washington University School of MedicineWithdrawn
-
Air Force Military Medical University, ChinaUnknownHepatocellular CarcinomaChina
-
GlaxoSmithKlineCompleted
-
Dana-Farber Cancer InstituteBayerCompletedMetastatic Renal Cell CarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBayerCompletedRectal CancerUnited States
-
Hospital San Carlos, MadridFoundation for Biomedical Research and InnovationCompletedCatheterization, PeripheralSpain
-
The Methodist Hospital Research InstituteNovartis PharmaceuticalsCompletedCarcinoma, Renal CellUnited States
-
M.D. Anderson Cancer CenterBayerCompletedAcute Myeloid Leukemia | AML | Myelodysplastic DisordersUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)CompletedHepatocellular CarcinomaUnited States
-
Merck Sharp & Dohme LLCNovartis PharmaceuticalsCompleted
-
Humanity & Health Medical Group LimitedRecruitingHepatocellular CarcinomaHong Kong
-
New Approaches to Neuroblastoma Therapy ConsortiumThe Hospital for Sick Children; Dana-Farber Cancer Institute; University of Chicago and other collaboratorsActive, not recruitingNeuroblastomaCanada, United States
-
Immunovative Therapies, Ltd.Mirror Biologics, Inc.Recruiting
-
St. Jude Children's Research HospitalActive, not recruitingAcute Myeloid Leukemia | Myelodysplastic SyndromesUnited States
-
Laval UniversityCompletedHip OsteoarthritisCanada
-
National Taiwan University HospitalCompletedHepatocellular CarcinomaTaiwan
-
St. Jude Children's Research HospitalActive, not recruiting
-
Becton, Dickinson and CompanyCompletedContrast Enhanced Computed TomographyUnited States
-
St. Jude Children's Research HospitalOhio State University; Arog Pharmaceuticals, Inc.CompletedAcute Myeloid LeukemiaUnited States
-
Nantes University HospitalCompleted
-
Washington University School of MedicineCompletedGlioma | Neuroectodermal Tumors, Primitive | Osteosarcoma | Sarcoma, Ewing | Retinoblastoma | Rhabdomyosarcoma | Wilms TumorUnited States
-
CelgeneCompletedClinical Pharmacology, Healthy Volunteer StudyUnited States
-
St. Jude Children's Research HospitalRecruitingHepatocellular Carcinoma | Pediatric Cancer | Malignant Solid Tumor | Fibrolamellar Carcinoma | Pediatric Solid Tumor | Refractory Solid TumorUnited States
-
CelgeneCompletedClinical Pharmacology, Healthy Volunteer StudyUnited States
-
University of ArkansasAmgenTerminatedMultiple MyelomaUnited States
-
Bristol-Myers SquibbAbbVieCompletedRelapsed and/or Refractory Multiple MyelomaSpain
-
CelgeneCompletedCentral Nervous System Neoplasms | MedulloblastomaUnited States, Italy, France, Spain, United Kingdom
-
Boehringer IngelheimTerminated
-
Case Comprehensive Cancer CenterCompletedMyelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Myelodysplastic/Myeloproliferative DiseasesUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers SquibbTerminatedMultiple MyelomaUnited States
-
Washington University School of MedicineTerminatedMultiple MyelomaUnited States
-
Sun Yat-sen UniversityUnknownRelapsed, Refractory, Multiple MyelomaChina
-
Emory UniversityTerminated
-
AmgenCompletedHealthy VolunteersUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisTerminatedMultiple MyelomaUnited States, Puerto Rico
-
M.D. Anderson Cancer CenterCompletedSolid TumorsUnited States